Form 4: Pfizer SVP & Controller Jennifer B. Damico Reports Acquisition of Phantom Stock Units

Jennifer B. Damico, SVP & Controller at Pfizer Inc., reported the acquisition of 49 phantom stock units through the Pfizer Supplemental Savings Plan on May 31, 2024.

Summary

• On May 31, 2024, Jennifer B. Damico, SVP & Controller of Pfizer Inc., acquired 49 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the underlying common stock at the time of acquisition was $28.66.
• Following the transaction, Damico directly owns 28,397 phantom stock units.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Future Outlook

The phantom stock units will be settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Industry Context

Form 4 filings are standard practice for corporate insiders to report transactions in their company's securities, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The acquisition of phantom stock units by a company insider can be seen as a positive sign, indicating confidence in the company's future performance.

Key Dates